Reply to Fujimoto <i>et al.</i>: Leveraging Microbiome Composition Variability for Precision Medicine in Idiopathic Pulmonary Fibrosis.

O'Dwyer, David N; Noth, Imre; Oldham, Justin M

Reply to Fujimoto et al.: Leveraging Microbiome Composition Variability for Precision Medicine in Idiopathic Pulmonary Fibrosis.

O'Dwyer, David N; Noth, Imre; Oldham, Justin M.

Afiliación

O'Dwyer DN; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; and.
Noth I; Division of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, Virginia.
Oldham JM; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; and.

Am J Respir Crit Care Med ; 210(4): 528-530, 2024 Aug 15.

Article en En | MEDLINE | ID: mdl-38271703

Asunto(s)

Fibrosis Pulmonar Idiopática; Microbiota; Medicina de Precisión; Fibrosis Pulmonar Idiopática/microbiología; Humanos; Medicina de Precisión/métodos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fibrosis Pulmonar Idiopática / Medicina de Precisión / Microbiota Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google